Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Kidney Neoplasms × Immunotherapy × Clear all

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 42 Lung Neoplasms 18 Melanoma 14 Neoplasm Metastasis 13 Carcinoma, Hepatocellular 13 Esophageal Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Breast Neoplasms 8 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Rectal Neoplasms 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Recurrence 4 Neoplasms 4 Carcinoma, Renal Cell 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Small Cell Lung Carcinoma 2 Radiation Pneumonitis 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2

Interventions

Sunitinib 26 Everolimus 20 Bevacizumab 19 aldesleukin 18 Sorafenib 16 Nivolumab 16 Interleukin-2 14 pembrolizumab 13 Peripheral Blood Stem Cell Transplantation 13 fludarabine phosphate 12 Radiotherapy 12 Interferon-alpha 12 Cyclophosphamide 12 Radiosurgery 11 Filgrastim 11 Blood Specimen Collection 11 Ipilimumab 10 Gemcitabine 10 Axitinib 9 Surveys and Questionnaires 7 Gene Expression Profiling 7 Cryosurgery 7 temsirolimus 6 pazopanib 6 Surgical Procedures, Operative 6 durvalumab 5 cabozantinib 5 atezolizumab 5 Mycophenolic Acid 5 Immunohistochemistry 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06583070 2026-01-28

COSTAR

Peking University First Hospital

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡